Pain News and Research

Latest Pain News and Research

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

Treating surfaces with cold atmospheric pressure plasma (CAPP) may reduce the risk of transmitting norovirus, a contagious virus leading to stomach pain, nausea and diarrhea, according to a new study.

14 Jan 2015

DMEK eye surgery at University Hospitals makes a world of difference for Ohio resident

"I was blind as a bat," said 73-year-old Parma, Ohio, resident John Barsa, who suffered from corneal edema, causing an abnormal accumulation of liquid in the eye leading to swelling of the cornea.

12 Jan 2015

ASA offers tips for safe surgery, anesthesia experience

Surgery and anesthesia are safer than ever, but most patients don't know about the steps they can and should take to make their experience safer and more comfortable.

12 Jan 2015

Circumcised boys more likely to develop autism spectrum disorder

Research published today by the Journal of the Royal Society of Medicine suggests that circumcised boys are more likely than intact boys to develop autism spectrum disorder (ASD) before the age of 10.

12 Jan 2015

Lack of information increases depression risk in people recovering from stroke

People recovering from a stroke and living at home have generally a higher risk of suffering from depression. According to researchers lack of information is often a major concern for patients and this frequently contributes to their depression. This is the result of a new study from health sociologists of the University of Luxembourg.

12 Jan 2015

Two new ODYSSEY trials meet primary efficacy endpoints

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that two new ODYSSEY trials, which are the first Phase 3 trials to assess alirocumab administered every four weeks, met their primary efficacy endpoints.

9 Jan 2015

Improving headache treatment could reduce health care spending, new study suggests

Each year more than 12 million Americans visit their doctors complaining of headaches, which result in lost productivity and costs of upward of $31 billion annually. A new study by researchers from Beth Israel Deaconess Medical Center suggests some of that cost could be offset by physicians ordering fewer tests and an increased focus on counseling about lifestyle changes.

8 Jan 2015

Study finds unnecessary hysterectomy in 1 out of 5 cases

It is estimated that one in three women in the United States will have had a hysterectomy by the age of 60. Although the numbers of hysterectomies are decreasing, a new study of more than three thousand women in Michigan who underwent hysterectomy for benign indications reveals that alternatives to hysterectomy are being underused and that treatment guidelines are often not followed.

7 Jan 2015

ContraVir granted Type B meeting with FDA to discuss proposal for FV-100 Phase 3 trial

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has been granted a Type B meeting with the U.S. Food and Drug Administration (FDA) to discuss its proposal for the design of a Phase 3 trial of ContraVir's lead antiviral candidate, FV-100.

7 Jan 2015

Taiwan Biophotonic releases DOE reflective sensor for fingerless wrist-worn pulse oximeters

Taiwan Biophotonic Co., a leading provider of non-invasive vital signs sensing solutions, today announced the release of its DOE reflective sensor for fingerless wrist-worn pulse oximeters, which makes a quantum leap forward in the wearable healthcare and medical devices.

7 Jan 2015

Study: Placental cells may possibly treat damaged nerves

New findings suggest that placental cells may potentially treat damaged nerves possibly leading the way to new treatment for stroke patients.

5 Jan 2015

Making New Year's resolution to control diabetes

José Rodriguez often skipped breakfast and lunch only to eat a large dinner at the end of the day. Despite his erratic eating habits, Mr. Rodriguez thought he was healthy until a routine blood test revealed he had type 2 diabetes.

2 Jan 2015

New study finds that exercise may improve lives of Parkinson's disease patients

Exercise may help people with Parkinson's disease improve their balance, ability to move around and quality of life, even if it does not reduce their risk of falling, according to a new study published in the December 31, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Jan 2015

Sex enhancement product recalled after Health Canada test finds undeclared drug ingredient

One lot of the sex enhancement product "Forta for Men" (NPN 80045132) is being recalled after Health Canada testing confirmed it contains an undeclared drug: homosildenafil.

31 Dec 2014

Synthetic Biologics doses first patient in SYN-004 Phase 1b trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced that enrollment has initiated and the first patient was dosed in a Phase 1b clinical trial of SYN-004, an investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.

31 Dec 2014

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA applications.

31 Dec 2014

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.

30 Dec 2014

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014

Newron, Zambon announce re-submission of safinamide NDA to FDA

Newron Pharmaceuticals S.p.A., a research and development company focused on novel CNS and pain therapies, and its commercial and development partner Zambon S.p.A., an international pharmaceutical company, announced today that the NDA for safinamide has been re-submitted to the US FDA.

29 Dec 2014

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Based on its recent analysis of the influenza vaccines market, Frost & Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award. Flublok is the world's first recombinant protein vaccine for the prevention of seasonal influenza disease to gain U.S. FDA approval.

29 Dec 2014

Pain News and Research

Latest Pain News and Research

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

DMEK eye surgery at University Hospitals makes a world of difference for Ohio resident

ASA offers tips for safe surgery, anesthesia experience

Circumcised boys more likely to develop autism spectrum disorder

Lack of information increases depression risk in people recovering from stroke

Two new ODYSSEY trials meet primary efficacy endpoints

Improving headache treatment could reduce health care spending, new study suggests

Study finds unnecessary hysterectomy in 1 out of 5 cases

ContraVir granted Type B meeting with FDA to discuss proposal for FV-100 Phase 3 trial

Taiwan Biophotonic releases DOE reflective sensor for fingerless wrist-worn pulse oximeters

Study: Placental cells may possibly treat damaged nerves

Making New Year's resolution to control diabetes

New study finds that exercise may improve lives of Parkinson's disease patients

Sex enhancement product recalled after Health Canada test finds undeclared drug ingredient

Synthetic Biologics doses first patient in SYN-004 Phase 1b trial to prevent C. difficile infection

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Newron, Zambon announce re-submission of safinamide NDA to FDA

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in